response to it? the one answer again, though, that does justify the attention is that it can't be good that omicron is now the dominant strain in south africa less than two weeks after it was first detected there. it is unusual growth. cases have climbed about ten fold in south africa over all from two weeks ago so a high transmissibility rate is a possibility if not a probability. we don't know for certain. that is why another aspect of the coverage, everybody is in a rush to bring on all the big pharma guys, the ceo of pfizer today said he thinks his company's current vaccine might work against the omicron variant but may offer less protection. he doesn't know. he is not certain. i don't know how that is helpful. but a chief medical officer said he is concerned with the specific mutations associated